vTv Therapeutics Inc. (VTVT) Free cash flow 2016–2024
vTv Therapeutics Inc. (VTVT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$25.3MFY2024 · since FY2016: -$48.3M → -$25.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$25.3M | -32.6% |
| FY2023 | -$19.1M | -18.9% |
| FY2022 | -$16.0M | +16.9% |
| FY2021 | -$19.3M | -7.3% |
| FY2020 | -$18.0M | +22.0% |
| FY2019 | -$23.1M | +14.0% |
| FY2018 | -$26.9M | +39.8% |
| FY2017 | -$44.6M | +7.6% |
| FY2016 | -$48.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice